Trial intelligence / Profile preview

Infiltrative ketorolac for pain relief after hemorrhoidectomy

IRCT20210922052556N1Phase 3Completed

Sponsor
Rafsanjan University of Medical Sciences
Start
May 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of ketorolac in hemorrhoid, sponsored by Rafsanjan University of Medical Sciences. Started May 2021; status: completed.

02

Drugs

ketorolac
03

Conditions

hemorrhoid

Beyond the preview

Go deeper on IRCT20210922052556N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210922052556N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call